American Association for Clinical Chemistry
Better health through laboratory medicine
2008 New Product Review

 


ARCHITECT® ci4100ä*

The Abbott ARCHITECT® ci4100 system delivers integration of clinical chemistry and immunoassay for low-to-mid-volume laboratories with productivity enhancements normally reserved for larger labs. The system employs identical technologies, reagents, and software used on the ARCHITECT ci8200® and ci16200™ immunochemistry systems to provide consistent performance and comparable results. The ci4100 uses the innovative Robotic Sample Handler design to deliver consistent stat turnaround times while processing up to 800 chemistry tests and up to 100 immunoassay tests per hour. The ci4100 is an easy-to-use system with a high level of technical sophistication rarely seen for the low-volume laboratory. * In development.

 


Abbott MULTIGENT Creatinine (Enzymatic)

The MULTIGENT Creatinine (Enzymatic) assay uses an enzymatic method that is sensitive and specific for creatinine and is not affected by endogenous substances, such as ketoacids, cephalosporins, and bilirubin that interfere with Jaffe methods. The MULTIGENT Creatinine (Enzymatic) assay is standardized to IDMS traceable NIST SRM 967 following the NKDEP, IFCC, and EC4 recommendation promoting the use of commutable reference material. Standardization and accuracy of serum creatinine measurements are critical for the estimation of renal function using the glomerular filtration rate (eGFR) equation. *Pending FDA clearance. Available outside the U.S.

 


Cardiac 3-in-1 (TnI, CKMB, MYO) Whole Blood/Serum Rapid Test

This rapid, qualitative immunoassay test is for professional use to aid in the diagnosis of myocardial infarctions at POC facilities, emergency department, or other hospital settings. The test operates with four drops of straight human whole blood or serum, and the results can be read within 10–15 minutes. Additional reagents are not required. It may be used along with a reader to provide a quantitative measurement of troponin I, CK-MB, and myoglobin. *Pending FDA clearance.

 


 ALFRED 60

The Alfred 60 is a fully automated system for urine culture that offers rapid results and reliability in sample identification and standardized working protocols. The patented technology allows detection of intense bacteria replication activity and plotting of the specific growth curves in real time, indicating the quantitative value expressed in CFU/mL. Strongly positive samples are flagged after only 45 minutes from the start of the analysis, and the positivity threshold can be customized according to the lab’s needs. A user can simultaneously perform the residual antimicrobial activity test and the culture test to avoid false-negative results caused by substances with antibacterial properties.
 


Combiscan/Combiscreen New Urinalysis Screening System

The superior urinalysis screening products from Analyticon, a leading company selling around the world, are now available in the U.S. CombiScan® readers and CombiScreen® strips, using advanced German product engineering, offer superior performance plus fast and cost-effective results. A choice of two CombiScan readers deliver automated high throughput that can link directly to patient and hospital databases. Importantly, CombiScreen strips cost 25% less than competing products from the major manufacturers. The overall system is an ideal entry-level, complete solution for laboratories looking for superior performance at affordable prices.


LabDAQ*

Antek HealthWare, LLC, is pleased to provide new functionality that will improve lab workflow and increase patient safety. The LabDAQ LIS includes an extensive rules engine, the ability to scan documents and attachments, and a report writer. The rules engine allows users to define a wide variety of rules when ordering, processing results, disseminating results, and billing. These user-defined rules allow labs to identify and select a wide variety of criteria and apply specific actions to satisfy those situational criteria. The rules are easy to use, flexible, and can accommodate virtually any action imaginable.


Cliquid® AA45 Software

New Cliquid AA45 Software from Applied Biosystems/MDS SCIEX simplifies the operation of LC/MS/MS for routine amino acid analysis into a simple four-step workflow. With an intuitive point-and-click interface, Cliquid AA45 Software provides pre-configured tests used with Applied Biosystems iTRAQ® reagents and chemistry for the analysis of up to 45 physiological amino acids in less than 25 minutes. The software also comes with a built-in compound catalogue and the ability to quickly create new assays for amino acids or other routine analysis. Please visit booth # 903 to learn more about our complete solution for amino acid analysis.

 


CVDefine™

CVDefine is a unique new marker for early detection of harmful lesions caused by immunological response and inflammation in the artery wall. CVDefine measures antibodies against phosphorylcholine (PC), one of the major epitopes on oxLDL. These antibodies are common from an early age and have an important role in development of cardiovascular disease. Low IgM anti-PC Ievels indicate an increased risk for cardiovascular disease, while high anti-PC levels predict a favorable outcome in atherosclerosis development in hypertensive patients. CVDefine provides an easy-to-use standard ELISA procedure for quantitative analysis of PC antibodies in human serum and plasma.

 


  INFINITI ™ 5.FU

The chemotherapeutic agent 5-fluorouracil (5-FU) is a broad-spectrum drug used in treatment of colorectal, gastric, pancreatic, head, neck, breast, ovarian, and cervical cancers. Many patients are genetically predisposed to adverse reactions to 5-FU. Dihydropyrimidine dehydrogenase (DPD) is responsible for more than 80% of the drug metabolism, and its polymorphisms are a potential cause of 5-FU chemotoxicity. Thymidine synthase (TS) is the target for 5-FU and may have a prognostic role in therapy outcome. The INFINITI 5-FU assay, automated on the Load N Go INFINITI Analyzer, provides comprehensive analysis of DPD, MTHFR and TS genetic variants to predict and to help prevent 5-FU-related adverse events.

 


 INFINITI HPV QUAD

The INFINITI HPV QUAD assay simultaneously detects 15 HPV types in a single patient sample (16, 18, 31, 33, 35, 45, 68, 39, 56, 58, 52, 59, 51, 6, and 11) and processes four patient samples on one BioFilmChip™ Microarray. HPV types 16, 18, 33, 45 and 59 have been associated with greater risk for developing both squamous and adenocarcinoma cervical cancers. With a turnaround time of 5.5 hours, 24 samples can be processed automatically with Load N Go workflow efficiency on the INFINITI™ Analyzer. *For research use only.
AutoGenomics


Stat Fax® 4500

The new Stat Fax 4500 is an economical chemistry analyzer with the same high-quality, six-filter optical system used in the Stat Fax 1904 model, with updated electronics and a large, touch-screen user interface. This versatile open system features calculations using factor, single calibrator, or multiple calibrators for kinetic and endpoint assays. It prints results on the internal thermal printer or outputs results to a PC to create custom-formatted reports.

 


Stat Fax® 4200

The new Stat Fax 4200 is a compact, economical, stand-alone microplate reader. It has a large touch-screen user interface and reads a standard 96-well microplate in less than 15 seconds. The versatile open system features cutoff modes, point-to-point, and regression calculations. It prints results on the internal thermal printer or outputs results to a PC to create custom-formatted reports.


Liquid Stable(LS) 2-Part Homocysteine reagent

The Liquid Stable(LS) 2-Part Homocysteine reagent is intended for in vitro quantitative determination of total homocysteine in plasma and serum (EDTA , Li-Hep, serum, and SST). The versatile assay employs two ready-to-use reagents and two calibrators and is standardized to the NIST SRM 1955 Homocysteine Reference Material. A key feature of the assay is the onboard reagent stability for 30 days that ensures a typical calibration stability of 14 days. The LS 2-Part assay demonstrates excellent correlation with both other immunoassays and HPLC methods. The test has a high throughput of up to 750 tests/hr and clinical protocols are available for many of the commonly used clinical chemistry analyzers.

 


ACL* TOP 500 CTS

The ACL TOP 500 CTS system is a fully automated, user-friendly instrument that helps mid- to high-volume labs maximize labor resources and improve patient care. The CTS feature eliminates the need to decap and recap, thereby increasing productivity and improving operator safety. This state-of-the-art system provides clotting, chromogenic, and immunoturbidimetric testing capabilities with a complete menu of routine and specialty assays, including D-Dimer HS. This powerful, intuitive system offers 24/7 continuous operation without interruption to workflow, allowing your lab to increase testing efficiency and reduce turnaround time. *In development

 


AutoMate™ 800 Sample Processing System

When you need to improve lab efficiency, turn to the AutoMate 800 from Beckman Coulter for an automation system that fits your unique requirements. The AutoMate 800 has everything you need to streamline pre- and post-analytical processes and position your lab for optimal performance and labor usage, including: single point of entry; advanced, automated sample loading and sorting; fully integrated centrifugation for faster test turnaround time with less variability; through-the-label sample volume detection; decapper module for maximum efficiency and safety; intelligent aliquotting and tube labeling to ensure faster, more accurate secondary tube preparation; and intuitive software to facilitate ease of use.


ELISA 5- in 1 Workstation

The walk-away solution for immunoassays in microplate format, the ELISA 5-in-1 Workstation combines the five basic functions to process ELISA assays in 96-well microplate format: washer, shaker, dispenser, incubator, and reader. Ideal for low-to-medium size labs, the compact instrument presents true walk-away functionality once the microplate has been placed into the loading/unloading position. The samples are fully processed according to the individual kit instructions, and the instrument allows easy transfer of manual ELISA assays, as well as robotic loading.

 


Lyophilized Reagent Delivery Systems

The ReActivator™ reagent delivery system incorporates manufacturers’ reagents in a lyophilized state (LyoSpheres™) and liquid diluents together inside of an easy-to-use disposable unit-of-use rehydrating and mixing dispenser. ReActivator provides your customers with pre-measured, convenient, precise, and contaminate-free, stable reagents. BIOLYPH has developed and designed 12 different models of ReActivator to meet a wide variety of needs. BIOLYPH will also customize a ReActivator model to meet your specific requirements. *Patent pending.

 


Antibody Shop

The DIA HE1 fully human IgE antibody is produced in vitro from a monoclonal hybridoma. This unique source guarantees high batch-to-batch consistency and freedom from contamination by other immunoglobulin isotypes. Suitable as a standard in IgE quantifying assays, the DIA HE1 antibody is comparable to the WHO standard 75/502 for IgE. Other applications include immunochemistry and cellular immunology research.


MBL Oligomer ELISA kit

A key test in the assessment of immune deficiencies, the Mannan-binding Lectin (MBL) assay is an important element in the innate immune defense. MBL deficiency is associated with increased susceptibility to infection. With more than 12% of the average population being MBL deficient, testing is a key parameter in the diagnosis of immune deficiencies. However, MBL deficiency is under-diagnosed because it is neglected in practice parameters. The MBL Oligomer ELISA Kit (KIT 029) is used in routine diagnostics in the EU, and it is the most cited assay for MBL determination worldwide.

 


NGAL Rapid ELISA Kit

An early biomarker of acute kidney injury, NGAL increases significantly within 2 hours after injury to the kidney. With the NGAL Rapid ELISA Kit (KIT 037) physicians can determine if patients will develop acute kidney failure with a 90% positive predictive value.